The trauma of the European currency crises in the 1990s and the consequences until today
September 2022 marked the 30th anniversary of the Exchange Rate Mechanism crisis, a seismic event which shook the continent and caused a severe recession to
How many people on earth? World population 1800-1938
Historical demography is important for research, but data have been limited to the most advanced countries. This column introduces newly estimated world populations for all
The peace dividend can be saved in Ukraine
The Russian invasion of Ukraine on 24 February 2022 brought back the spectre of a nuclear war, WWIII, and other potential horrors. This column argues
Twitter to charge users to secure accounts via text message
Twitter said on Friday it will allow only paid subscribers to use text messages as a two-factor authentication (2FA) method to secure their accounts. After
Vietnam’s EV maker VinFast recalls nearly 2,800 units domestically
Vietnam’s electric vehicle (EV) maker VinFast is recalling 2,781 of its sports utility model VF8 sold in the domestic market to check and replace the
Lockheed Martin gets U.S. Navy contract worth up to $2 billion
The U.S. Navy has awarded Lockheed Martin Corp a contract worth up to $2 billion related to hypersonic weapon systems, the defense firm said on Friday,
Amazon asks employees to be in office at least three days a week
Amazon.com Inc would require employees to be in office at least three days a week from May 1, the e-commerce giant said on Friday. The COVID-19
Biden, 80, is healthy, ‘fit for duty,’ doctor says after physical
Doctors declared U.S. President Joe Biden, 80, healthy and “fit for duty” on Thursday after a physical examination that included removing a lesion from his
U.S. seeks $175,000 fine from SpaceX over failure to submit Starlink data
The Federal Aviation Administration (FAA) on Friday proposed a $175,000 civil penalty against SpaceX for failing to submit some safety data to the agency prior
U.S. FDA approves Travere Therapeutics kidney disorder drug
Travere Therapeutics said on Friday the U.S. health regulator has granted accelerated approval to its drug to treat a type of chronic kidney disease, IgAN, in
